A goal for measles elimination globally by 2010–2020 was recognized as one of the priorities in the WHO program “Health for All in the 21st Century” (1998). However measles outbreaks occurred in 2010–2016 in countries with high level of measles vaccine coverage including USA and some European countries.Large measles outbreaks were also registered on the African continent and particular in the Republic of Guinea as a result of the decline of measles vaccine coverage due to the Ebola virus epidemic in the Republic of Guinea in 2014–2015. WHO recommends carrying out the routine measles vaccination as well as the supplemental immunization activities after the stop of the Ebola virus transmission. Effectiveness of the activities is definitely connected with the detection of the epidemically significant for the supplemental immunization age groups. The aim of the study was to evaluate the measles immunity level in different age groups of population in the Republic of Guinea. Materials and methods. Twenty five blood serum samples of healthy adult Guineans aged 28–66 and 121 blood serum samples of adolescences and adults admitted to hospital in the town of Kindia (Republic of Guinea) for indoor treatment were tested by ELISA. The specific measles virus antibodies were detected using the following commercial ELISA test-systems produced by Euroimmun Medizinische Labordiagnostika AG Company (Germany): IgM-antibodies — by “Anti-Measles Virus ELISA (IgM)”, IgG-antibodi es — by “Anti-Measles Virus ELISA (IgG)”, IgG-avidity measles virus antibodies — by “Avidity: Anti-Measles Virus ELISA (IgG)”. A part of sera was studied by “Vector-Best IgM-measles” and “Vector-Best IgG-measles” ELISA test-systems (Russia). Results and discussion. The comparative quantitative study of the measles immunity level (i.e. IgG-antibodies titers) of the healthy adult Guineans in 2015 and 2016 revealed the lack of IgGantibodies in serum of only one person aged 30. In 68.7% of cases studied the IgG-antibodies titers didn’t change significantly during the year. In the most part (68.0%) of the 25 tested sera the high levels of the IgG-antibodies titers were detected (≥ 1000 IU/L). In addition the IgG-antibodies of high avidity were revealed in the most part (87.5%) of blood serum samples thus evidencing the history of measles virus infection in the past among the examined adults aged 28+. The ELISA studies of 121 blood serum samples from patients with different clinical diagnosis being on indoor treatment in the hospital of the town of Kindia (Republic of Guinea) revealed 21 anti-measles IgG negative patients. Among patients with the known age (n = 113) IgG-antibodies to measles virus were determined in 78.8% of the samples tested. At the same time in each age group the seronegative patients as well as the patients with low titers of the specific IgG-antibodies to measles virus were revealed. Among patients of 18–40 years of age the part of seronegative patients was equal to 28.5±5.1%. This cohort may be susceptible to measles virus infection and facilitate the support as well as the development of active epidemic process in case of measles outbreaks in the Republic of Guinea.
Parvovirus infection (PVI) is an important but little-known problem in the Russian Federation. Its clinical manifestations are characterized by different clinical entities that require differential diagnosis, as with other viral infections, as well as non-communicable diseases and epidemiological significance of PVI determined the prevalence of the development of epidemic outbreaks, mainly in organized groups. Medical and social - with teratogenic virus, as well as the possibility of its transmission at gematransfuziyah. The main risk groups - pregnant women, patients hematological profile. In the absence of recording and reporting the incidence of people is impossible to establish the scale of the spread of parvovirus infection. Crucial in this respect are laboratory studies that reveal the prevalence of its laboratory markers.
An improved technology for the industrial production of K3 series vitamins based on menadion is reported. The procedure involves the Cr(VI)-promoted oxidation of the corresponding methyl-naphtahelenes with the following purification by precipitation/recrystallization. The best results were obtained under the process temperature between 20-40 °C, solution pH after dilution of MNB in a range of 5.5–5.7, and MNB content in initial solution of 25-30%.
The review is devoted to the analysis of the available literature on the elimination of measles. The review focuses on the current measles epidemic situation in the African Region (AFR) and the implementation of the WHO strategic plan for the elimination of measles in AFR by 2020. Measles in the AFR is characterized by a severe course with a high risk of death due to malnutrition, vitamin A deficiency, concomitant bacterial and viral infections, and malaria. In 2015, 105,256 cases of measles were reported in the WHO African Region, most of them among children under 5 years old, 79% of whom were not vaccinated or had unknown vaccine status. Initially, the strategy for implementing the measles elimination program in AFRs was based on a combination of immunization campaigns for children under 14 years of age (coverage of more than 90%) and routine vaccination of at least 90% of children aged 9–15 months. It was recommended to repeat the campaign of mass immunization of children aged 9 months up to 4 years every 3–5 years. The use of this strategy has reduced the number of measles cases by 83–97% during the first year of additional immunization programs. The recommended age of routine measles vaccination in AFRs is 9 months — a strategy to reduce infant mortality, including that due to complications of measles. In 2016, measles vaccination was introduced into the national immunization schedule in all AFR countries, and 24 countries introduced revaccination. Currently, the measles elimination program in a number of AFR countries is based on two-dose immunization (MCV1 and MCV2). The measles prevention program in a number of AFR countries was disrupted due to the Ebola epidemic. There are some common problems in the realization of the program in AFR countries. All AFR countries are committed to the measles elimination program. The review provides information on strategies and successes in overcoming challenges to achieve the goals set for the WHO African Region in the implementation of the programme of measles elimination.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.